Stockreport

Global Respiratory Disease Testing Market to Grow at a CAGR of ~4% by 2030 | DelveInsight

Verona Pharma plc - American Depositary Shares  (VRNA) 
US:NASDAQ Investor Relations: nasdaq.com/symbol/vrna/real-time
PDF The growing demand for respiratory disease testing is largely driven by the increasing global prevalence of respiratory disorders. Furthermore, the rising risk factors l [Read more]